Zealand Pharma A/S Stock Nasdaq
Equities
ZEAL
US98920Y3045
Biotechnology & Medical Research
Sales 2024 * | 694M 99.97M | Sales 2025 * | 1.14B 164M | Capitalization | 38.58B 5.56B |
---|---|---|---|---|---|
Net income 2024 * | -383M -55.17M | Net income 2025 * | -272M -39.18M | EV / Sales 2024 * | 51.8 x |
Net cash position 2024 * | 2.61B 376M | Net cash position 2025 * | 2.69B 387M | EV / Sales 2025 * | 31.5 x |
P/E ratio 2024 * |
-101
x | P/E ratio 2025 * |
-714
x | Employees | 253 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.25% |
Latest transcript on Zealand Pharma A/S
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 09-12-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Ivan M. Møller
COO | Chief Operating Officer | 52 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Kruimer
BRD | Director/Board Member | 66 | 19-04-03 |
Chairman | 69 | 14-12-31 | |
Kirsten Drejer
BRD | Director/Board Member | 68 | 18-04-18 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.96% | 23.07B | |
-12.60% | 22.23B | |
-5.10% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |